JPH11103801A - Composition containing quinua skin and food - Google Patents

Composition containing quinua skin and food

Info

Publication number
JPH11103801A
JPH11103801A JP9274624A JP27462497A JPH11103801A JP H11103801 A JPH11103801 A JP H11103801A JP 9274624 A JP9274624 A JP 9274624A JP 27462497 A JP27462497 A JP 27462497A JP H11103801 A JPH11103801 A JP H11103801A
Authority
JP
Japan
Prior art keywords
skin
quinua
cholesterol
food
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9274624A
Other languages
Japanese (ja)
Other versions
JP3897262B2 (en
Inventor
Yotaro Konishi
洋太郎 小西
Ryota Minoguchi
亮太 蓑口
Tetsuya Takao
哲也 高尾
Goro Kenmasa
五郎 堅正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAINIPPON MEIJI SEITO KK
Original Assignee
DAINIPPON MEIJI SEITO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAINIPPON MEIJI SEITO KK filed Critical DAINIPPON MEIJI SEITO KK
Priority to JP27462497A priority Critical patent/JP3897262B2/en
Publication of JPH11103801A publication Critical patent/JPH11103801A/en
Application granted granted Critical
Publication of JP3897262B2 publication Critical patent/JP3897262B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cereal-Derived Products (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition ingestable in the form as it is, by easily adding to food, etc., excellent in medicinal efficacy, useful for the prophylaxis and treatment of atheroscrelosis, etc., and reducing cholesterol by containing a quinua skin or a treated material thereof. SOLUTION: This composition containing a quinua skin contains 0.5-100 wt.% powdery or a skin-shaped quinua skin obtained as a bran portion by threshing the quinua seeds by a rice polisher, or a quinua treated material obtained by further crushing the quinua skin finely to form a powder, extracting the obtained powder with a solvent such as methanol, and purifying the obtained extract with a chromatography, a dialysis, etc. Further, it is preferable to prepare a food by formulating the quinua skin or a treated material thereof, and the amount of intake of the quinua skin or the treated material thereof is preferably in a range of 0.5-60 g for an adult daily.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、キヌア皮、もしく
はキヌア皮に含まれる成分を含んだ組成物及び食品に関
する。詳しくは、経口的に摂取することにより血中コレ
ステロールや肝中コレステロールを低下させることので
きる組成物及び食品に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition and food containing quinoa skin or a component contained in quinoa skin. Specifically, the present invention relates to a composition and a food capable of lowering blood cholesterol and hepatic cholesterol when taken orally.

【0002】[0002]

【従来の技術】近年血中コレステロールと動脈硬化、心
筋梗塞など様々な疾病との関係が明らかにされており、
これらの疾病を含む糖尿病、大腸ガンなどの生活習慣病
による死亡率が増加している。これは生活水準の向上に
ともない、高脂肪高たんぱく質の欧米型食品への食餌パ
ターンの移行や、いわゆる精製加工食品への嗜好が強ま
った結果であると言われている。このような状況の中
で、また健康指向の高まりなどから、健康を自己管理す
る必要性が唱えられており、コレステロール低下作用を
有する健康食品等の開発が望まれている。コレステロー
ル低下作用を持ち、持地食品として利用できるものに
は、各種食物繊維が知られている。しかしながら、これ
ら食物繊維のコレステロール低下効果を期待するには食
品中に食物繊維を5-10重量%以上添加しなければなら
ず、食品の物性や食味に影響を与えるため、簡易に摂取
することが困難であった。
2. Description of the Related Art In recent years, the relationship between blood cholesterol and various diseases such as arteriosclerosis and myocardial infarction has been clarified.
Mortality due to lifestyle-related diseases such as diabetes and colorectal cancer including these diseases is increasing. This is said to be the result of a shift in dietary patterns to high-fat, high-protein Western foods and an increase in preference for so-called refined and processed foods along with improvements in living standards. Under such circumstances, the need for self-management of health has been advocated due to the growing health orientation and the like, and development of health foods and the like having a cholesterol-lowering effect has been desired. Various dietary fibers are known to have a cholesterol lowering effect and to be used as local foods. However, in order to expect the cholesterol lowering effect of these dietary fibers, it is necessary to add 5-10% by weight or more of dietary fiber to the food, which affects the physical properties and taste of the food. It was difficult.

【0003】[0003]

【発明が解決しようとする課題】本発明は、簡易に食品
などへ添加できるか、もしくはそのままの形で経口摂取
可能なコレステロール低下作用を有する組成物及び該組
成物を含む食品を提供することを目的とする。本発明者
らは鋭意検討の結果、経口摂取可能なキヌア皮にコレス
テロール低下作用があることを見出し、発明を完成する
に至った。今までに、キヌアに血中コレステロールや肝
中コレステロールを低下させる等の生理活性が認められ
たとの報告はなされていない。
The object of the present invention is to provide a composition having a cholesterol-lowering effect which can be easily added to foods or the like and which can be taken orally as it is, and a food containing the composition. Aim. As a result of intensive studies, the present inventors have found that orally ingestible quinoa skin has a cholesterol-lowering effect, and have completed the invention. To date, there have been no reports that quinoa has been found to have any physiological activity such as lowering blood cholesterol or hepatic cholesterol.

【0004】[0004]

【課題を解決するための手段】本発明は、以下の発明を
包含する。 (1)キヌア皮またはその処理物を含有するコレステロ
ールを低下させるための組成物。 (2)キヌア皮またはその処理物を含有する食品。
The present invention includes the following inventions. (1) A composition for lowering cholesterol containing quinoa skin or a processed product thereof. (2) A food containing quinoa skin or a processed product thereof.

【0005】[0005]

【発明の実施の形態】キヌア(Chenopodium Quinoa:キ
ノポディウムキヌア)はアカザ科に属する穀物の一種で
あり、その種子は中南米において食用にされ、一部主食
としてもしくは加工食品として利用されている。本発明
者らは、キヌア種子を皮部と穀物部に分け検討を行った
結果、皮部にコレステロールを低下させる作用があるこ
とを見出した。
BEST MODE FOR CARRYING OUT THE INVENTION Quinopodium ( Chinopodium Quinoa ) is a kind of cereal belonging to the family Acatheaceae, and its seeds are eaten in Central and South America, and are partially used as staple food or processed food. The present inventors have studied quinoa seeds by dividing them into bark and cereal portions, and as a result, have found that bark has an effect of lowering cholesterol.

【0006】ここでいうキヌア皮とは、キヌア種子を精
米機にて脱穀し、糠部分として得られた粉体もしくは皮
状のもののことであり、これらを更に細かく粉砕して粉
末化したもの、適当な溶媒にて抽出したもの、前記抽出
物を更にクロマトグラフィーや透析等により精製したも
のをキヌア皮処理物という。キヌア皮の粉砕は、ボール
ミル、臼、ブレンダー、粉砕器等の通常の粉砕・粉末化
手段にて行うことができる。
[0006] The term "quinoa skin" as used herein refers to a powder or skin-like product obtained by threshing quinoa seeds with a rice mill and obtaining a bran portion. A product extracted with an appropriate solvent, and a product obtained by further purifying the above extract by chromatography, dialysis, or the like, are referred to as a treated quinoa skin. The pulverization of the quinoa skin can be performed by a usual pulverizing / pulverizing means such as a ball mill, a mortar, a blender, and a pulverizer.

【0007】キヌア皮を抽出する場合には、抽出溶媒と
して水、メタノール、エタノール、プロパノール、ブタ
ノール等のアルコール類、エチルエーテル、ジオキサン
等のエーテル類、アセトン等のケトン類などを用いるこ
とができる。抽出物を一旦溶媒除去して乾燥物として用
いる場合には、前述した任意の溶媒を単独でまたは混合
して用いることができる。一方、抽出物を溶媒に溶解し
た状態で用いる場合には、人体に対して有害な作用を示
さない溶媒を用いる必要があり、この場合には、水、エ
タノールまたはこれらの混合物を用いることが好まし
い。抽出温度は好ましくは室温ないし溶媒の常圧下での
沸点の範囲内であり、抽出時間は抽出温度等により異な
るが、好ましくは48時間以内である。このようにして
得られた抽出物はそのまま本発明の組成物及び食品に用
いることができ、また当該抽出物を更にイオン交換クロ
マトグラフィー、ゲル濾過クロマトグラフィー、透析等
の各種精製手段により精製したものを用いてもよい。
In the case of extracting quinoa skin, water, alcohols such as methanol, ethanol, propanol and butanol, ethers such as ethyl ether and dioxane, and ketones such as acetone can be used as an extraction solvent. When the extract is used once as a dried product after removing the solvent, any of the above-mentioned solvents can be used alone or as a mixture. On the other hand, when the extract is used in a state of being dissolved in a solvent, it is necessary to use a solvent that does not show harmful effects on the human body, and in this case, it is preferable to use water, ethanol, or a mixture thereof. . The extraction temperature is preferably within the range of room temperature to the boiling point of the solvent under normal pressure. The extraction time varies depending on the extraction temperature and the like, but is preferably within 48 hours. The extract thus obtained can be used as it is in the composition and food of the present invention, and the extract is further purified by various purification means such as ion exchange chromatography, gel filtration chromatography, and dialysis. May be used.

【0008】本発明の組成物は、キヌア皮またはその処
理物を0.5〜100重量%含有するものである。本発明の組
成物の有効摂取量は、摂取者の年齢、体重、血中または
肝中コレステロールのレベル等によって異なり、摂取量
の上限に関しては特に制限はないが、他の栄養素とのバ
ランスを考慮して適宜選択することが望ましい。通常、
キヌア皮またはその処理物として成人一日当たり0.5〜6
0gであり、一回または数回に分けて摂取することがで
きる。本発明の組成物は、賦形剤、結合剤、着色料、香
料等をキヌア皮またはその処理物と混合し、造粒や、温
風乾燥・真空乾燥・噴霧乾燥・凍結乾燥などの一般的な
乾燥方法により乾燥することにより得られる。
[0008] The composition of the present invention contains quinoa skin or a processed product thereof in an amount of 0.5 to 100% by weight. The effective intake of the composition of the present invention depends on the age, weight, blood or hepatic cholesterol level of the user, and the upper limit of the intake is not particularly limited, but the balance with other nutrients is taken into consideration. It is desirable to select as appropriate. Normal,
0.5 to 6 per day for adults as quinoa skin or its processed product
It is 0 g and can be taken once or in several divided doses. The composition of the present invention is obtained by mixing an excipient, a binder, a coloring agent, a flavoring agent and the like with quinoa skin or a processed product thereof, and granulating the mixture, using a general method such as hot air drying, vacuum drying, spray drying, and freeze drying. It is obtained by drying by a suitable drying method.

【0009】賦形剤としては、例えばデンプン、乳糖、
白糖、マンニット、カルボキシメチルセルロース、コー
ンスターチ、無機塩類などが挙げられる。結合剤として
は、デンプン、コーンスターチ、寒天や増粘多糖類、カ
ゼインなどの蛋白質などが挙げられる。組成物の形態と
しては特に制限はなく、必要に応じて適宜選択される
が、一般には粉剤、顆粒剤、カプセル剤、錠剤等が挙げ
られる。
As excipients, for example, starch, lactose,
Sucrose, mannitol, carboxymethylcellulose, corn starch, inorganic salts and the like. Examples of the binder include starch, corn starch, agar, a thickening polysaccharide, and proteins such as casein. The form of the composition is not particularly limited and may be appropriately selected as necessary, but generally includes powders, granules, capsules, tablets and the like.

【0010】キヌア皮またはその処理物は食品に添加・
加工することが可能であるため、摂取を更に容易かつ簡
便にすることができる。キヌア皮またはその処理物を添
加・加工できる食品の形態としては、特に制限はなく必
要に応じて適宜選択されるが、一般には各種健康食品や
パン、菓子類(クッキー、スナック等)といった加工食
品が挙げられ、この他にもシロップ剤やドリンク剤など
が挙げられる。本発明の組成物の原料であるキヌア皮
は、キヌア種子の一部として食用に供されており、安全
性は確立されている。
[0010] Quinoa peel or its processed product is added to food.
Because it can be processed, ingestion can be made easier and simpler. The form of the food to which quinoa rind or its processed product can be added and processed is not particularly limited and may be appropriately selected as needed. In general, processed foods such as various health foods and breads and confectionery (cookies, snacks, etc.) And syrups and drinks. Quinoa skin, which is a raw material of the composition of the present invention, is edible as a part of quinoa seeds, and its safety has been established.

【0011】[0011]

【実施例】以下、実施例により本発明を更に具体的に説
明するが、本発明の範囲はこれらの実施例に限定される
ものではない。なお、本実施例中、特に記載がない限り
%は全て重量に基づくものとする。参考例1 キヌア皮の調製例 キヌア種子を精米機を用いて三分つきで脱穀した。この
とき得られた糠部をキヌア皮として取得した。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples, but the scope of the present invention is not limited to these Examples. In this example, all percentages are based on weight unless otherwise specified. Reference Example 1 Preparation Example of Quinoa Peel Quinoa seeds were threshed in three minutes using a rice mill. The bran obtained at this time was obtained as quinoa skin.

【0012】実施例1 血中コレステロール低下試験 (1)血中総コレステロール量の測定 ICR雄マウス(7週齢、体重約30g)31匹を、おがくず
を敷いたプラスチックケースに1匹ずつ入れ、固形飼料
を与えた。12日後、これらのうちから無作為に選びだし
た9匹についてあらかじめ血中総コレステロール量を測
定し、これら9匹を含む31匹に1%コレステロールを含む
コントロール食を与えた。1週間後(この日を0日とす
る)再び血中総コレステロール量を測定し、1週間で血
中総コレステロール量が上昇したのを確認した後、これ
らの血中総コレステロール量の平均値がほぼ同じになる
ように4群に分け、それぞれコントロール食、大豆サポ
ニンを1%含む食餌(1%SS食)、参考例1で得られたキ
ヌア皮を1.5%含む食餌(1.5%QSF食)、同じくキヌア
皮を3%含む食餌(3%QSF食)を与えて5週間飼育し
た。水は自由に与えた。その間、1週毎に血中総コレス
テロール量を測定した。キヌア皮にはサポニンが含まれ
ていることより、大豆サポニンをキヌア皮に対する対照
物質として用いた。
Example 1 Blood cholesterol lowering test (1) Measurement of total blood cholesterol amount 31 ICR male mice (7 weeks old, weighing about 30 g) were placed one by one in a plastic case covered with sawdust, and solidified. Feed was given. Twelve days later, the blood total cholesterol level of 9 randomly selected animals was measured in advance, and 31 of these 9 mice were fed a control diet containing 1% cholesterol. One week later (this day is defined as day 0), the total blood cholesterol level was measured again, and after confirming that the total blood cholesterol level had risen in one week, the average value of these total blood cholesterol levels was calculated. Divided into 4 groups so as to be almost the same, a control diet, a diet containing 1% soybean saponin (1% SS diet), a diet containing 1.5% quinoa skin obtained in Reference Example 1 (1.5% QSF diet), Similarly, they were fed a diet containing 3% quinoa skin (3% QSF diet) and raised for 5 weeks. Water was given ad libitum. During that time, the total blood cholesterol level was measured weekly. Since quinoa skin contains saponin, soybean saponin was used as a control substance for quinoa skin.

【0013】結果を図1に示す。固形飼料で予備飼育(-
1週〜0週)後、1%コレステロールを含むコントロール
食を与えると、血中総コレステロール量が約1.5倍に上
昇した。その後各食餌で飼育すると、第1週目にコント
ロール群と1%SS群の値が更に上昇したのに対し、1.5
%QSF群と3%QSF群の値は下降した(3%QSF群
はp<0.05)。その後4群ともに下降し、第5週目の3%Q
SF群においては固形飼料を摂取しているマウスの値と
ほぼ同じになった。コントロール群と比べるとQSF群
は有意に低かった(第1、2、5週の1.5%QSF群、第5
週の3%QSF群がp<0.05、第1〜3週の3%QSF群はp
<0.01)。1%SS群と比べてもQSF群は有意に低か
った(第1〜3週の1.5%及び3%QSF群はp<0.01、第5
週の1.5%及び3%QSF群がp<0.05)。これらのこと
より、キヌア皮には、高コレステロール食摂取マウスに
おいて血中総コレステロール量の上昇を抑制する働きが
あることが判明した。
FIG. 1 shows the results. Preliminary feeding on solid feed (-
After 1 week to 0), when a control diet containing 1% cholesterol was given, the total blood cholesterol level increased about 1.5 times. After feeding on each diet, the values in the control group and the 1% SS group further increased in the first week, whereas the values in the control group and the 1% SS group increased by 1.5%.
The values of the% QSF group and the 3% QSF group decreased (p <0.05 for the 3% QSF group). After that, all 4 groups descended, 3% Q in the 5th week
In the SF group, the value was almost the same as the value of the mice receiving the solid feed. The QSF group was significantly lower than the control group (1.5% QSF group at weeks 1, 2, and 5;
P <0.05 for weekly 3% QSF group, p for week 1 to 3% QSF group
<0.01). The QSF group was significantly lower than the 1% SS group (p <0.01 for the 1.5% and 3% QSF
1.5% and 3% QSF groups weekly p <0.05). From these results, it was revealed that quinoa skin has a function of suppressing an increase in the total blood cholesterol level in mice on a high cholesterol diet.

【0014】(2)血中HDLコレステロール量の測定 ICR雄マウス(7週齢、体重約30g)31匹を、おがくず
を敷いたプラスチックケースに1匹ずつ入れ、固形飼料
を与えた。12日後、これらのうちから無作為に選びだし
た9匹についてあらかじめ血中総コレステロール量を測
定し、これら9匹を含む31匹にコントロール食を与え
た。1週間後(この日を0日とする)再び総コレステロー
ル量を測定し、1週間で血中総コレステロール量が上昇
したのを確認した後、これらの血中総コレステロール量
の平均値がほぼ同じになるように4群に分け、それぞれ
コントロール食、1%SS食、1.5%QSF食、3%QS
F食を与えて5週間飼育した。水は自由に与えた。5週目
に血中総コレステロール量、血中HDLコレステロール
量を測定した。HDLは血管壁に蓄積したコレステロー
ルを除去し、また血管壁へコレステロールを運び込むL
DLと拮抗すると言われており、そのため血中のHDL
コレステロールの割合が高いほど、動脈硬化などの生活
習慣病に対する危険が少なくなると考えられる。
(2) Measurement of Blood HDL Cholesterol Amount 31 ICR male mice (7 weeks old, weighing about 30 g) were placed one by one in a plastic case covered with sawdust and fed a solid feed. Twelve days later, the blood total cholesterol level was previously measured for nine randomly selected animals from among them, and 31 animals including these nine were fed a control diet. One week later (this day is defined as day 0), the total cholesterol level was measured again, and after confirming that the total blood cholesterol level had increased in one week, the average values of these total blood cholesterol levels were almost the same. Divided into 4 groups to become control food, 1% SS food, 1.5% QSF food, 3% QS respectively
They were fed F diet and raised for 5 weeks. Water was given ad libitum. At week 5, the total blood cholesterol level and the blood HDL cholesterol level were measured. HDL removes cholesterol accumulated in the blood vessel wall and transports cholesterol to the blood vessel wall.
It is said to antagonize DL and therefore HDL in blood
It is believed that the higher the proportion of cholesterol, the lower the risk for lifestyle-related diseases such as arteriosclerosis.

【0015】5週目における4群の血中総コレステロール
量及び血中HDLコレステロール量を図2に、血中総コ
レステロールに対する血中HDLコレステロールの割合
を図3に示した。血中HDLコレステロールの絶対量に
関しては各群間で特に差はみられなかったが、血中総コ
レステロールに対する血中HDLコレステロールの割合
はコントロール群に比べて他の3群はいずれも高い値を
示し、特に3%QSF群は有意に高かった(p<0.05)。
これらのことより、キヌア皮には、高コレステロール食
摂取マウスにおいて血中総コレステロール中におけるH
DLコレステロールの占める割合を上昇させる働きがあ
ることが判明した。
FIG. 2 shows the blood total cholesterol level and blood HDL cholesterol level of the four groups at week 5, and FIG. 3 shows the ratio of blood HDL cholesterol to blood total cholesterol level. The absolute amount of blood HDL cholesterol was not particularly different between the groups, but the ratio of blood HDL cholesterol to the total blood cholesterol was higher in the other three groups than in the control group. In particular, the 3% QSF group was significantly higher (p <0.05).
From these results, it was found that quinoa skin contained H in total blood cholesterol in mice on a high cholesterol diet.
It has been found that DL cholesterol has a function of increasing the ratio.

【0016】実施例2 肝中コレステロール低下試験 ICR雄マウス(7週齢、体重約30g)31匹を、おがくず
を敷いたプラスチックケースに1匹ずつ入れ、固形飼料
を与えた。12日後、これらのうちから無作為に選びだし
た9匹についてあらかじめ血中総コレステロール量を測
定し、これら9匹を含む31匹にコントロール食を与え
た。1週間後(この日を0日とする)再び血中総コレステ
ロール量を測定し、1週間で血中総コレステロール量が
上昇したのを確認した後、これらの血中総コレステロー
ルの平均値がほぼ同じになるように4群に分け、それぞ
れコントロール食、1%SS食、1.5%QSF食、3%Q
SF食を与えて5週間飼育した。水は自由に与えた。飼
育5週目に肝中総コレステロール量を測定した
Example 2 Liver cholesterol lowering test 31 ICR male mice (7 weeks old, weighing about 30 g) were placed one by one in a plastic case covered with sawdust and fed a solid feed. Twelve days later, the blood total cholesterol level was previously measured for nine randomly selected animals from among them, and 31 animals including these nine were fed a control diet. One week later (this day is defined as day 0), the blood total cholesterol level was measured again, and after confirming that the blood total cholesterol level had risen in one week, the average value of these blood total cholesterol levels was almost unchanged. Divide into 4 groups to be the same, control food, 1% SS food, 1.5% QSF food, 3% Q respectively
They were fed an SF diet and raised for 5 weeks. Water was given ad libitum. Liver total cholesterol was measured at 5 weeks of breeding

【0017】飼育5週目におけるマウスの肝重量と肝中
総コレステロール量を表1に示す。各群の肝臓を比較し
たところ、コントロール群や1%SS群の肝臓は脂肪肝
のように白みを帯びていたが、1.5%QSF群及び3%Q
SF群の肝臓の色は正常マウスと同様赤色を呈してい
た。肝中総コレステロール量は、コントロール群に比べ
てQSF群で有意に低い値を示した。
Table 1 shows the liver weight and the total liver cholesterol level of the mice at week 5 of breeding. When the livers of each group were compared, the livers of the control group and the 1% SS group were whitish like fatty liver, but the livers of the 1.5% QSF group and the 3% Q
The liver color of the SF group was red as in the normal mice. The total liver cholesterol level was significantly lower in the QSF group than in the control group.

【0018】[0018]

【表1】 これらのことより、キヌア皮には、高コレステロール食
摂取マウスにおいて肝中総コレステロール量の上昇を抑
制する働きがあることが判明した。
[Table 1] From these results, it was revealed that quinoa skin has a function of suppressing an increase in the total liver cholesterol level in mice on a high cholesterol diet.

【0019】実施例3 キヌア皮を含む組成物の調製例 参考例1で得られたキヌア皮を、含有量が1.5重量%にな
るよう賦形剤(マルトデキストリンベース)と混合し
た。混合後、押出し造粒機により造粒し、80℃の熱風乾
燥により乾燥し、顆粒状の組成物を得た。
Example 3 Preparation Example of Composition Containing Quinoa Skin Quinoa skin obtained in Reference Example 1 was mixed with an excipient (maltodextrin base) so that the content was 1.5% by weight. After mixing, the mixture was granulated by an extrusion granulator and dried by hot-air drying at 80 ° C. to obtain a granular composition.

【0020】実施例4 キヌア皮を含む食品の調製例 (1)健康食品 参考例1で得られたキヌア皮を、6.0重量%となるよう
に還元乳糖、甘味料、ビタミンC、乳化剤と共に混合し
た。混合後、押出し造粒機により造粒し、80℃の温風乾
燥により乾燥して顆粒品を得た。この顆粒品0.5gを打
錠し、タブレット状の食品を得た。
Example 4 Preparation Example of Food Containing Quinoa Skin (1) Healthy Food The quinoa skin obtained in Reference Example 1 was mixed with reduced lactose, a sweetener, vitamin C, and an emulsifier so as to be 6.0% by weight. . After mixing, the mixture was granulated by an extrusion granulator and dried by hot air drying at 80 ° C. to obtain a granule. 0.5 g of the granule was tableted to obtain a tablet-like food.

【0021】(2)クッキー 参考例1で得られたキヌア皮を、3.0%となるように薄
力粉、バター、砂糖、卵と共に混合し、4〜5cmの円筒状
に整えて1時間4℃に維持し、クッキー生地とした。クッ
キー生地を約5mmの厚さに切断し、予め180℃に予熱した
オーブンを用いて12分間加熱し、クッキーを作製した。
(2) Cookies The quinoa skin obtained in Reference Example 1 is mixed with flour, butter, sugar, and eggs so as to have a concentration of 3.0%, prepared into a cylindrical shape of 4 to 5 cm, and maintained at 4 ° C. for 1 hour. And cookie dough. The cookie dough was cut into a thickness of about 5 mm, and heated in an oven preheated to 180 ° C. for 12 minutes to produce a cookie.

【0022】[0022]

【発明の効果】本発明によれば、そのままの形で経口摂
取可能であり、また食品などへも簡易に添加できるコレ
ステロール低下作用を有する組成物及び該組成物を含む
食品が提供される。
According to the present invention, there is provided a composition having a cholesterol-lowering effect which can be orally ingested as it is and which can be easily added to foods and the like, and a food containing the composition.

【図面の簡単な説明】[Brief description of the drawings]

【図1】キヌア皮の摂取によるマウス血中総コレステロ
ール量の変化を示す図。
FIG. 1 is a graph showing changes in the total blood cholesterol level in mice due to ingestion of quinoa skin.

【図2】血中総コレステロール及びHDLコレステロー
ル量を示す図。
FIG. 2 is a graph showing total cholesterol and HDL cholesterol levels in blood.

【図3】血中総コレステロール量中のHDLコレステロ
ール量の割合を示す図。
FIG. 3 is a view showing the ratio of the amount of HDL cholesterol in the total amount of cholesterol in blood.

フロントページの続き (51)Int.Cl.6 識別記号 FI A61K 35/78 ADN A61K 35/78 ADNC (72)発明者 堅正 五郎 東京都中央区日本橋1−5−3 大日本明 治製糖株式会社内Continued on the front page (51) Int.Cl. 6 Identification code FI A61K 35/78 ADN A61K 35/78 ADNC (72) Inventor Gosho Kensei 1-5-3 Nihonbashi, Chuo-ku, Tokyo Dainippon Meiji Sugar Co., Ltd. Inside

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 キヌア皮またはその処理物を含有するコ
レステロールを低下させるための組成物。
1. A composition for lowering cholesterol, comprising quinoa skin or a processed product thereof.
【請求項2】 キヌア皮またはその処理物を含有する食
品。
2. A food containing quinoa skin or a processed product thereof.
JP27462497A 1997-10-07 1997-10-07 Quinoa skin-containing composition and food Expired - Lifetime JP3897262B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27462497A JP3897262B2 (en) 1997-10-07 1997-10-07 Quinoa skin-containing composition and food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27462497A JP3897262B2 (en) 1997-10-07 1997-10-07 Quinoa skin-containing composition and food

Publications (2)

Publication Number Publication Date
JPH11103801A true JPH11103801A (en) 1999-04-20
JP3897262B2 JP3897262B2 (en) 2007-03-22

Family

ID=17544319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27462497A Expired - Lifetime JP3897262B2 (en) 1997-10-07 1997-10-07 Quinoa skin-containing composition and food

Country Status (1)

Country Link
JP (1) JP3897262B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002167334A (en) * 2000-11-30 2002-06-11 Dainippon Meiji Seito Kk Composition with quinoa embryo bud
GB2420066A (en) * 2004-11-23 2006-05-17 Nor Feed As Feed additive derived from plant material originating from quinoa (Chenopodium quinoa)
WO2007126017A1 (en) * 2006-04-27 2007-11-08 Uha Mikakuto Co., Ltd. Agent for suppressing arteriosclerosis
JP5834160B1 (en) * 2015-06-26 2015-12-16 山中 直樹 Bread and method for producing the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500024A (en) * 1993-08-10 1997-01-07 ユニリーバー・ナームローゼ・ベンノートシャープ Rye flour
JPH09502869A (en) * 1993-09-17 1997-03-25 ケロッグ・カンパニー Extruded and pre-wet instant cereal containing plantain

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500024A (en) * 1993-08-10 1997-01-07 ユニリーバー・ナームローゼ・ベンノートシャープ Rye flour
JPH09502869A (en) * 1993-09-17 1997-03-25 ケロッグ・カンパニー Extruded and pre-wet instant cereal containing plantain

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL & PHARMACEUTICAL BULLETIN, vol. Vol.36,No.4(1988), JPNX006040309, pages 1415 - 1418, ISSN: 0000768522 *
CHEMICAL & PHARMACEUTICAL BULLETIN, vol. Vol.36,No.4(1988), JPNX006056870, pages 1415 - 1418, ISSN: 0000793784 *
CHEMICAL & PHARMACEUTICAL BULLETIN, vol. Vol.38,No.2(1990), JPNX006040310, pages 375 - 377, ISSN: 0000768523 *
CHEMICAL & PHARMACEUTICAL BULLETIN, vol. Vol.38,No.2(1990), JPNX006056871, pages 375 - 377, ISSN: 0000793785 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002167334A (en) * 2000-11-30 2002-06-11 Dainippon Meiji Seito Kk Composition with quinoa embryo bud
GB2420066A (en) * 2004-11-23 2006-05-17 Nor Feed As Feed additive derived from plant material originating from quinoa (Chenopodium quinoa)
WO2007126017A1 (en) * 2006-04-27 2007-11-08 Uha Mikakuto Co., Ltd. Agent for suppressing arteriosclerosis
JP5834160B1 (en) * 2015-06-26 2015-12-16 山中 直樹 Bread and method for producing the same

Also Published As

Publication number Publication date
JP3897262B2 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
KR19990063480A (en) Compositions Effective in Reducing Obesity and Foods and Beverages Containing the Same
JPWO2013099982A1 (en) Muscle atrophy inhibitor
JP2008063332A (en) Immature persimmon fruit powder composition and method for producing the same
JP4401659B2 (en) Insulin secretagogue
EP1583547B1 (en) Anti-obesity ingredients from medicinal plants and their composition
JP2011020925A (en) Offal fat-type overweight inhibitor and method for producing the same
JP3897262B2 (en) Quinoa skin-containing composition and food
JP2005170836A (en) Marine alga extract and lipase inhibitor containing the same
JP2008184459A (en) Calcium absorption accelerating composition
JP3807464B2 (en) Anti-obesity agent
JP2670742B2 (en) α-amylase inhibitor
JP2014505071A (en) Plant extract preparation process
JP4783550B2 (en) Colon cancer inhibitor and food containing the same
JP3345650B2 (en) Hypertension inhibitor
JP2000166499A (en) Health food with blended hericium erinaceum
JP3142192B2 (en) Blood lipid improving agent and composition containing the same
JPH02101016A (en) Remedy for kidney disease and food for recovery of kidney disease
CN110710672A (en) Natural plant active calcium preparation and preparation method thereof
JP2009029748A (en) Colon cancer suppressing agent using chinese yam
JP5192215B2 (en) Immunostimulatory composition
JPWO2008111651A1 (en) Metabolic syndrome improving or preventing agent, and beverage, food and feed containing the same
JP2004244396A (en) Tnf-alpha production inhibitor
JP2005022994A (en) Hypoglycemic composition
JPS60172926A (en) Healthy food
JPH11139982A (en) Medicine for cancer inhibition

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20040827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20041102

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060905

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20061205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20061215

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110105

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120105

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130105

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130105

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140105

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term